Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 8, 2019.

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
76045-210-10
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)
Initial Posting
Feb 8, 2019

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.